
₹14,868(14 Shares)
Minimum Investment
IPO Dates
Dec 8, 2025 – Dec 10, 2025
Price Band
₹1008–1062 per equity share
Lot Size
14
Listing
Dec 15, 2025
Listing At
BSE, NSE
NII Sub-Categories
sHNI (< ₹10L)
Bids ₹2L to ₹10L
bHNI (> ₹10L)
Bids above ₹10L
Overall Subscription
Total Bids Received
144.49x
Shares Offered
9,16,960
Shares Offered
12,21,729
Shares Offered
18,34,804
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and othe...
EPS (Pre-IPO)
24.43
EPS (Post-IPO)
30.21
P/E (Pre-IPO)
43.47
P/E (Post-IPO)
35.15
RoNW
24.65%
PAT Margin
12.49%
P/B Value
10.71
Market Cap
6495.20 Cr.
* All figures are in ₹ Crores unless otherwise stated.
CORONA House, C – Mondeal Business Park, Near Gurudwara S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380059
Bigshare Services Pvt Ltd
The Corona Remedies Limited IPO price band is set at ₹1008.00 to ₹1062.00 per equity share.
The lot size for Corona Remedies Limited IPO is 14 shares per lot. The minimum investment amount is approximately ₹14,868.
The Corona Remedies Limited IPO opens on Dec 8, 2025 and closes on Dec 10, 2025.
Corona Remedies Limited IPO is expected to be listed on Dec 15, 2025 on BSE, NSE.
The current GMP for Corona Remedies Limited IPO is ₹300, suggesting an expected listing price of around ₹1308.00. Note: GMP is an unofficial market indicator.
The registrar for Corona Remedies Limited IPO is Bigshare Services Pvt Ltd. You can contact them at ipo@bigshareonline.com.